Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering dendritic cell vaccines to improve cancer immunotherapy
Caleb R. Perez, Michele De Palma
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 389

Showing 1-25 of 389 citing articles:

Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 998
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 375
Exosome-based immunotherapy: a promising approach for cancer treatment
Zhijie Xu, Shuangshuang Zeng, Zhicheng Gong, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 358
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 343
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Mengyu Chang, Zhiyao Hou, Man Wang, et al.
Advanced Materials (2020) Vol. 33, Iss. 4
Closed Access | Times Cited: 329
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
Cathrine Lund Lorentzen, John B.A.G. Haanen, Özcan Met, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 10, pp. e450-e458
Open Access | Times Cited: 295
mRNA therapeutics in cancer immunotherapy
Jan D. Beck, Daniel Reidenbach, Nadja Salomon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 257
Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse, Sophia M. Vrba, Natalie M. Kirk, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 242
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari, Michele Graciotti, Michal Bassani‐Sternberg, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 635-652
Closed Access | Times Cited: 220
Genetic models of human and mouse dendritic cell development and function
David A. Anderson, Charles‐Antoine Dutertre, Florent Ginhoux, et al.
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 101-115
Closed Access | Times Cited: 216
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Aadhya Tiwari, Rakesh Trivedi, Shiaw‐Yih Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178
Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics
Abhimanyu Thakur, Diana Carolina Parra, Pedram Motallebnejad, et al.
Bioactive Materials (2021) Vol. 10, pp. 281-294
Open Access | Times Cited: 176
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 173
GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer
Zhanwei Zhou, Hui Wu, Ruoxi Yang, et al.
Science Advances (2020) Vol. 6, Iss. 36
Open Access | Times Cited: 154
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 136
Thermal immuno-nanomedicine in cancer
Zhe Yang, Di Gao, Jing Zhao, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 116-134
Closed Access | Times Cited: 131
Nanobiomaterial-based vaccination immunotherapy of cancer
Fangmin Chen, Yingjie Wang, Jing Gao, et al.
Biomaterials (2021) Vol. 270, pp. 120709-120709
Closed Access | Times Cited: 112
Engineered nanomaterials for synergistic photo-immunotherapy
Ranran Guo, Siqi Wang, Lin Zhao, et al.
Biomaterials (2022) Vol. 282, pp. 121425-121425
Closed Access | Times Cited: 99
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 81
Advances in PET imaging of cancer
Johannes Schwenck, Dominik Sonanini, Jonathan Cotton, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 474-490
Closed Access | Times Cited: 81
RNA therapeutics: updates and future potential
Caroline Zhang, Biliang Zhang
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 12-30
Open Access | Times Cited: 75
Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma
Xiaoyue Ma, Lei Kuang, Ying Yin, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2341-2355
Closed Access | Times Cited: 70
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 70
Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells
Xiaowu Bai, Chi Chun Wong, Yasi Pan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003663-e003663
Open Access | Times Cited: 68
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top